ACV meeting #23, 30 July 2021

The 23rd meeting of the Advisory Committee on Vaccines (ACV), July 2021.

Date

30 July 2021

The meeting of the Advisory Committee on Vaccines (ACV).

The committee provided advice on one application to register a new vaccine, and one application to extend the indications of the vaccine.

The committee provided advice on one matter relating to pharmacovigilance.

COVID-19 vaccine AstraZeneca [now, Vaxzevria] and Guillain Barre Syndrome

Members

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.

Outcomes

ACV meeting statement, Meeting 23, 30 July 2021

3 November 2021

Meeting statements

Advisory Committee on Vaccines meeting statement

Topics

Committees and advisory bodies

Meeting of

Advisory Committee on Vaccines (ACV)

Related content

Sharing information about the safety, quality and performance of medical devices - lunchtime session

15 September 2026

Webinars

We are seeking feedback on a proposal to improve information sharing about the safety, quality and performance of medical devices.
Sharing information about the safety, quality and performance of medical devices - evening session

15 September 2026

Webinars

We are seeking feedback on a proposal to improve information sharing about the safety, quality and performance of medical devices.